Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP636978.RA4vrj_8v5abEuAAVNMYidsWhZPofW7F53CN_c4Urwa5A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP636978.RA4vrj_8v5abEuAAVNMYidsWhZPofW7F53CN_c4Urwa5A130_assertion type Assertion NP636978.RA4vrj_8v5abEuAAVNMYidsWhZPofW7F53CN_c4Urwa5A130_head.
- NP636978.RA4vrj_8v5abEuAAVNMYidsWhZPofW7F53CN_c4Urwa5A130_assertion description "[As evaluated by MTT assays, gefitinib (EGFR inhibitor) and DIM-C (PPAR? agonist) inhibited growth of 9 bladder cancer cell lines in a dose-dependent manner but with variable sensitivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP636978.RA4vrj_8v5abEuAAVNMYidsWhZPofW7F53CN_c4Urwa5A130_provenance.
- NP636978.RA4vrj_8v5abEuAAVNMYidsWhZPofW7F53CN_c4Urwa5A130_assertion evidence source_evidence_literature NP636978.RA4vrj_8v5abEuAAVNMYidsWhZPofW7F53CN_c4Urwa5A130_provenance.
- NP636978.RA4vrj_8v5abEuAAVNMYidsWhZPofW7F53CN_c4Urwa5A130_assertion SIO_000772 23409107 NP636978.RA4vrj_8v5abEuAAVNMYidsWhZPofW7F53CN_c4Urwa5A130_provenance.
- NP636978.RA4vrj_8v5abEuAAVNMYidsWhZPofW7F53CN_c4Urwa5A130_assertion wasDerivedFrom befree-20150227 NP636978.RA4vrj_8v5abEuAAVNMYidsWhZPofW7F53CN_c4Urwa5A130_provenance.
- NP636978.RA4vrj_8v5abEuAAVNMYidsWhZPofW7F53CN_c4Urwa5A130_assertion wasGeneratedBy ECO_0000203 NP636978.RA4vrj_8v5abEuAAVNMYidsWhZPofW7F53CN_c4Urwa5A130_provenance.